A single-center experience of transsphenoidal endoscopic surgery for acromegaly in 73 patients: results and predictive factors for remission

References

• Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'. Eur J Endocrinol 2005;152:379–87.
   PubMed Web of Science ®Google Scholar
• Holdaway IM, Rajasoorya C. Epidemiology of acromegaly. Pituitary 1999;2:29–41.
   PubMedGoogle Scholar
• Hazer DB, Işık S, Berker D, et al. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria. JNS 2013;119:1467–77.
   PubMed Web of Science ®Google Scholar
• Hofstetter CP, Mannaa RH, Mubita L, et al. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas. FOC 2010;29:E6.
   Google Scholar
• Orme SM, McNally RJ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 1998;83:2730–4.
   PubMed Web of Science ®Google Scholar
• Pines A, Rozen P, Ron E, Gilat T. Gastrointestinal tumors in acromegalic patients. Am J Gastroenterol 1985;80:266–9.
   PubMed Web of Science ®Google Scholar
• Klein I, Parveen G, Gavaler JS, Vanthiel DH. Colonic polyps in patients with acromegaly. Ann Intern Med 1982;97:27–30.
   PubMed Web of Science ®Google Scholar
• Ceylan S, Koc K, Anik I. Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus. J Neurosurg 2010;112:99–107.
   PubMed Web of Science ®Google Scholar
• Freda PU. Current concepts in the biochemical assessment of the patient with acromegaly. Growth Horm IGF Res 2003;13:171–84.
   PubMed Web of Science ®Google Scholar
• Giustina A, Barkan A, Casanueva FF, et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 2000;85:526–9.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Rajaratnam S, Chacko G, Chacko AG. Endocrinological outcomes following endoscopic and microscopic transsphenoidal surgery in 113 patients with acromegaly. Clin Neurol Neurosurg 2014;126:190–5.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Ironside N, Pomeraniec IJ, et al. Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications. Acta Neurochir 2017;159:2193–207.
   PubMed Web of Science ®Google Scholar
• Nishioka H, Fukuhara N, Horiguchi K, Yamada S. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes. JNS 2014;121:505–10.
   PubMedGoogle Scholar
• Rick J, Jahangiri A, Flanigan PM, et al. Growth hormone and prolactin-staining tumors causing acromegaly: a retrospective review of clinical presentations and surgical outcomes. J Neurosurg 2018;131:147–53.
   PubMed Web of Science ®Google Scholar
• Jane JA, Starke RM, Elzoghby MA, et al. Endoscopic transsphenoidal surgery for acromegaly: Remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab 2011;96:2732–40.
   PubMed Web of Science ®Google Scholar
• Giustina A, Chanson P, Bronstein MD, Acromegaly Consensus Group, et al. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 2010;95:3141–8.
   PubMed Web of Science ®Google Scholar
• Cunha M. d, Borba LAB, Boguszewski CL. Random Gh and Igf-I levels after transsphenoidal surgery for acromegaly: relation with long-term remission. Endocrine 2020;68:182–91.
   PubMed Web of Science ®Google Scholar
• Melmed S, Casanueva FF, Cavagnini F, Acromegaly Treatment Consensus Workshop Participants, et al. Guidelines for acromegaly management. J Clin Endocrinol Metab 2002;87:4054–8.
   PubMed Web of Science ®Google Scholar
• Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Neurosurg Focus 2010;29:E5.
   PubMed Web of Science ®Google Scholar
• Asha MJ, Takami H, Velasquez C, et al. Long-term outcomes of transsphenoidal surgery for management of growth hormone-secreting adenomas: single-center results. J Neurosurg. Published Online 2019;1–11. Online ahead of print. doi: 10.3171/2019.6.JNS191187.
   Google Scholar
• Babu H, Ortega A, Nuno M, et al. Long-term endocrine outcomes following endoscopic endonasal transsphenoidal surgery for acromegaly and associated prognostic factors. Neurosurgery 2017;81:357–66.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang Z, Guo H, et al. Direct transcavernous sinus approach for endoscopic endonasal resection of intracavernous sinus tumors. World Neurosurg 2019;128:e478–e487.
   PubMed Web of Science ®Google Scholar
• Ludecke DK, Abe T. Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations. Neuroendocrinology 2006;83:230–9.
   PubMed Web of Science ®Google Scholar
• Biermasz NR, van Dulken H, Roelfsema F. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. J Clin Endocrinol Metab 2000;85:4596–602.
   PubMed Web of Science ®Google Scholar
• Swearingen B, Barker FG, Katznelson L, et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998;83:3419–26.
   PubMed Web of Science ®Google Scholar
• Laws ER, Vance ML, Thapar K. Pituitary surgery for the management of acromegaly. Horm Res Paediatr 2000;53: 71–5.
   Web of Science ®Google Scholar
• Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 1998;83:3411–8.
   PubMed Web of Science ®Google Scholar
• Wilson TJ, McKean EL, Barkan AL, Chandler WF, Sullivan SE. Repeat endoscopic transsphenoidal surgery for acromegaly: remission and complications. Pituitary 2013;16:459–64.
   PubMed Web of Science ®Google Scholar
• Kurosaki M, Luedecke DK, Abe T. Effectiveness of secondary transnasal surgery in GH-secreting pituitary macroadenomas. Endocr J 2003;50:635–42.
   PubMed Web of Science ®Google Scholar
• Yamada S, Fukuhara N, Oyama K, Takeshita A, Takeuchi Y. Repeat transsphenoidal surgery for the treatment of remaining or recurring pituitary tumors in acromegaly. Neurosurgery 2010;67:949–56.
   PubMed Web of Science ®Google Scholar
• Halmi NS. Occurrence of both growth hormone- and prolactin-immunoreactive material in the cells of human somatotropic pituitary adenomas containing mammotropic elements. Virchows Arch A Pathol Anat Histopathol 1982;398:19–31.
   PubMedGoogle Scholar
• Robert F, Pelletier G, Serri O, Hardy J. Mixed growth hormone and prolactin-secreting human pituitary adenomas: A pathologic, immunocytochemical, ultrastructural, and immunoelectron microscopic study. Hum Pathol 1988;19:1327–34.
   PubMed Web of Science ®Google Scholar
• Nyquist P, Laws ER, Elliott E. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly. Neurosurgery 1994;35:179–83.
   PubMed Web of Science ®Google Scholar
• Roca E, Penn DL, Safain MG, Burke WT, Castlen JP, Laws ER. Abdominal fat graft for sellar reconstruction: retrospective outcomes review and technical note. Oper Neurosurg 2019;16:667–74.
   Web of Science ®Google Scholar
• Wang YY, Higham C, Kearney T, Davis JRE, Trainer P, Gnanalingham KK. Acromegaly surgery in Manchester revisited - The impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission. Clin Endocrinol 2012;76:399–406.
   PubMed Web of Science ®Google Scholar